Role of microRNAs in hepatocellular carcinoma: a clinical perspective

References

• ParkinDMBrayFFerlayJPisaniPGlobal cancer statistics, 2002CA Cancer J Clin20055527410815761078
   PubMed Web of Science ®Google Scholar
• JemalACenterMMDeSantisCWardEMGlobal patterns of cancer incidence and mortality rates and trendsCancer Epidemiol Biomarkers Prev20101981893190720647400
   PubMed Web of Science ®Google Scholar
• BoschFXRibesJCleriesRDiazMEpidemiology of hepatocellular carcinomaClin Liver Dis20059219121115831268
   PubMed Web of Science ®Google Scholar
• FaraziPADePinhoRAHepatocellular carcinoma pathogenesis: from genes to environmentNat Rev Cancer20066967468716929323
   PubMed Web of Science ®Google Scholar
• PurohitVRapakaRKwonOSSongBJRoles of alcohol and tobacco exposure in the development of hepatocellular carcinomaLife Sci20139213923123447
   PubMed Web of Science ®Google Scholar
• WuHCSantellaRThe role of aflatoxins in hepatocellular carcinomaHepat Mon20121210 HCCe723823162603
   PubMed Web of Science ®Google Scholar
• UccelloMMalaguarneraGCorriereTBiondiABasileFMalaguarneraMRisk of hepatocellular carcinoma in workers exposed to chemicalsHepat Mon20121210 HCCe594323162599
   PubMed Web of Science ®Google Scholar
• StarleyBQCalcagnoCJHarrisonSANonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connectionHepatology20105151820183220432259
   PubMed Web of Science ®Google Scholar
• DraganiTARisk of HCC: genetic heterogeneity and complex geneticsJ Hepatol201052225225720022654
   PubMed Web of Science ®Google Scholar
• ShrimalAPrasanthMKulkarniAVInterventional radiological treatment of hepatocellular carcinoma: an updateIndian J Surg2012741919923372313
   PubMed Web of Science ®Google Scholar
• Abou-AlfaGKSchwartzLRicciSPhase II study of sorafenib in patients with advanced hepatocellular carcinomaJ Clin Oncol200624264293430016908937
   PubMed Web of Science ®Google Scholar
• LlovetJMRicciSMazzaferroVSorafenib in advanced hepatocellular carcinomaN Engl J Med2008359437839018650514
   PubMed Web of Science ®Google Scholar
• KaneRCFarrellATMadabushiRSorafenib for the treatment of unresectable hepatocellular carcinomaOncologist20091419510019144678
   PubMed Web of Science ®Google Scholar
• KostnerAHSorensenMOlesenRKGronbaekHLassenULadekarlMSorafenib in advanced hepatocellular carcinoma: a nationwide retrospective study of efficacy and tolerabilityScientific World Journal2013201393197223431262
   PubMed Web of Science ®Google Scholar
• PadhyaKTMarreroJASingalAGRecent advances in the treatment of hepatocellular carcinomaCurr Opin Gastroenterol201026318919520224395
   PubMed Web of Science ®Google Scholar
• BaiWWangYJZhaoYSorafenib in combination with transarterial chemoembolization improves survival of unresectable hepatocellular carcinoma: a propensity-score matching studyJ Dig Dis201314418119023324079
   PubMed Web of Science ®Google Scholar
• ZhaoYWangWJGuanSSorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patientsAnn Oncol318201324717869223508822
   PubMed Web of Science ®Google Scholar
• BartelDPMicroRNAs: genomics, biogenesis, mechanism, and functionCell2004116228129714744438
   PubMed Web of Science ®Google Scholar
• Griffiths-JonesSmiRBase: microRNA sequences and annotationCurr Protoc Bioinformatics2010 Chapter 12: Unit 12.9.1–10
   Google Scholar
• Davis-DusenberyBNHataAMechanisms of control of microRNA biogenesisJ Biochem2010148438139220833630
   PubMed Web of Science ®Google Scholar
• FaraziTAHoellJIMorozovPTuschlTMicroRNAs in human cancerAdv Exp Med Biol201377412023377965
   PubMed Web of Science ®Google Scholar
• CalinGACroceCMMicroRNA signatures in human cancersNat Rev Cancer200661185786617060945
   PubMed Web of Science ®Google Scholar
• NegriniMFerracinMSabbioniSCroceCMMicroRNAs in human cancer: from research to therapyJ Cell Sci2007120Pt 111833184017515481
   PubMed Web of Science ®Google Scholar
• CostineanSZanesiNPekarskyYPre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic miceProc Natl Acad Sci U S A2006103187024702916641092
   PubMed Web of Science ®Google Scholar
• SantanamUZanesiNEfanovAChronic lymphocytic leukemia modeled in mouse by targeted miR-29 expressionProc Natl Acad Sci U S A201010727122101221520566844
   PubMed Web of Science ®Google Scholar
• EnomotoYKitauraJHatakeyamaKEmu/miR-125b transgenic mice develop lethal B-cell malignanciesLeukemia201125121849185621738213
   PubMed Web of Science ®Google Scholar
• ZhaoJLRaoDSBoldinMPTaganovKDO’ConnellRMBaltimoreDNF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignanciesProc Natl Acad Sci U S A2011108229184918921576471
   PubMed Web of Science ®Google Scholar
• MedinaPPNoldeMSlackFJOncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphomaNature20104677311869020693987
   PubMed Web of Science ®Google Scholar
• KleinULiaMCrespoMThe DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemiaCancer Cell2010171284020060366
   PubMed Web of Science ®Google Scholar
• NegriniMGramantieriLSabbioniSCroceCMmicroRNA involvement in hepatocellular carcinomaAnticancer Agents Med Chem201111650052121554203
   PubMed Web of Science ®Google Scholar
• HouJLinLZhouWIdentification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinomaCancer Cell201119223224321316602
   PubMed Web of Science ®Google Scholar
• Lagos-QuintanaMRauhutRYalcinAMeyerJLendeckelWTuschlTIdentification of tissue-specific microRNAs from mouseCurr Biol200212973573912007417
   PubMed Web of Science ®Google Scholar
• XuHHeJHXiaoZDLiver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver developmentHepatology20105241431144220842632
   PubMed Web of Science ®Google Scholar
• EsauCDavisSMurraySFmiR-122 regulation of lipid metabolism revealed by in vivo antisense targetingCell Metab200632879816459310
   PubMed Web of Science ®Google Scholar
• KrutzfeldtJStoffelMMicroRNAs: a new class of regulatory genes affecting metabolismCell Metab20064191216814728
   PubMed Web of Science ®Google Scholar
• BaiSNasserMWWangBMicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenibJ Biol Chem200928446320153202719726678
   PubMed Web of Science ®Google Scholar
• MaLLiuJShenJExpression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cellsCancer Biol Ther20109755456120150764
   PubMed Web of Science ®Google Scholar
• FornariFGramantieriLGiovanniniCMiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cellsCancer Res200969145761576719584283
   PubMed Web of Science ®Google Scholar
• TsaiWCHsuPWLaiTCMicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinomaHepatology20094951571158219296470
   PubMed Web of Science ®Google Scholar
• CoulouarnCFactorVMAndersenJBDurkinMEThorgeirssonSSLoss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic propertiesOncogene200928403526353619617899
   PubMed Web of Science ®Google Scholar
• HsuSHWangBKotaJEssential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liverJ Clin Invest201212282871288322820288
   PubMed Web of Science ®Google Scholar
• TsaiWCHsuSDHsuCSMicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesisJ Clin Invest201212282884289722820290
   PubMed Web of Science ®Google Scholar
• GramantieriLFerracinMFornariFCyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinomaCancer Res200767136092609917616664
   PubMed Web of Science ®Google Scholar
• JensenMRFactorVMFantozziAHelinKHuhCGThorgeirssonSSReduced hepatic tumor incidence in cyclin G1-deficient miceHepatology200337486287012668979
   PubMed Web of Science ®Google Scholar
• LinCJGongHYTsengHCWangWLWuJLmiR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell linesBiochem Biophys Res Commun2008375331532018692484
   PubMed Web of Science ®Google Scholar
• MurakamiYYasudaTSaigoKComprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissuesOncogene200625172537254516331254
   PubMed Web of Science ®Google Scholar
• JiangJGusevYAdercaIAssociation of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survivalClin Cancer Res200814241942718223217
   PubMed Web of Science ®Google Scholar
• JiaXQChengHQQianXLentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinomaCell Biochem Biophys201262123724421847633
   PubMed Web of Science ®Google Scholar
• FornariFMilazzoMChiecoPMiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cellsCancer Res201070125184519320501828
   PubMed Web of Science ®Google Scholar
• KimSLeeUJKimMNMicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2)J Biol Chem200828326181581816618456660
   PubMed Web of Science ®Google Scholar
• WangCSongBSongWUnderexpressed microRNA-199b-5p targets hypoxia-inducible factor-1alpha in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patientsJ Gastroenterol Hepatol201126111630163721557766
   PubMed Web of Science ®Google Scholar
• HenryJCParkJKJiangJmiR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell linesBiochem Biophys Res Commun2010403112012521055388
   PubMed Web of Science ®Google Scholar
• ShenQCicinnatiVRZhangXRole of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasionMol Cancer2010922720799954
   PubMed Web of Science ®Google Scholar
• FornariFGramantieriLFerracinMMiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinomaOncogene200827435651566118521080
   PubMed Web of Science ®Google Scholar
• MedinaRZaidiSKLiuCGMicroRNAs 221 and 222 bypass quiescence and compromise cell survivalCancer Res20086882773278018413744
   PubMed Web of Science ®Google Scholar
• GarofaloMDi LevaGRomanoGmiR-221 and 222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulationCancer Cell200916649850919962668
   PubMed Web of Science ®Google Scholar
• PineauPVoliniaSMcJunkinKmiR-221 overexpression contributes to liver tumorigenesisProc Natl Acad Sci U S A2010107126426920018759
   PubMed Web of Science ®Google Scholar
• CallegariEElaminBKGiannoneFLiver tumorigenicity promoted by microRNA-221 in a mouse transgenic modelHepatology20125631025103322473819
   PubMed Web of Science ®Google Scholar
• GramantieriLFornariFFerracinMMicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocalityClin Cancer Res200915165073508119671867
   PubMed Web of Science ®Google Scholar
• VoliniaSCalinGALiuCGA microRNA expression signature of human solid tumors defines cancer gene targetsProc Natl Acad Sci U S A200610372257226116461460
   PubMed Web of Science ®Google Scholar
• ChanJAKrichevskyAMKosikKSMicroRNA-21 is an antiapoptotic factor in human glioblastoma cellsCancer Res200565146029603316024602
   PubMed Web of Science ®Google Scholar
• SiMLZhuSWuHLuZWuFMoYYmiR-21-mediated tumor growthOncogene200726192799280317072344
   PubMed Web of Science ®Google Scholar
• BuscagliaLELiYApoptosis and the target genes of microRNA-21Chin J Cancer201130637138021627859
   PubMedGoogle Scholar
• MengFHensonRWehbe-JanekHGhoshalKJacobSTPatelTMicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancerGastroenterology2007133264765817681183
   PubMed Web of Science ®Google Scholar
• AsanganiIARasheedSANikolovaDAMicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancerOncogene200827152128223617968323
   PubMed Web of Science ®Google Scholar
• FrankelLBChristoffersenNRJacobsenALindowMKroghALundAHProgrammed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cellsJ Biol Chem200828321026103317991735
   PubMed Web of Science ®Google Scholar
• FerracinMVeroneseANegriniMMicromarkers: miRNAs in cancer diagnosis and prognosisExpert Rev Mol Diagn201010329730820370587
   PubMed Web of Science ®Google Scholar
• MinguezBLachenmayerADiagnostic and prognostic molecular markers in hepatocellular carcinomaDis Markers201131318119022045404
   PubMed Web of Science ®Google Scholar
• BarshackIMeiriERosenwaldSDifferential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expressionInt J Biochem Cell Biol20104281355136220619223
   PubMed Web of Science ®Google Scholar
• HessKRVaradhacharyGRTaylorSHMetastatic patterns in adenocarcinomaCancer200610671624163316518827
   PubMed Web of Science ®Google Scholar
• CortezMACalinGAMicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseasesExpert Opin Biol Ther20099670371119426115
   PubMed Web of Science ®Google Scholar
• QiJWangJKatayamaHSenSLiuSMCirculating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinomaNeoplasma111220136021354223259781
   PubMed Web of Science ®Google Scholar
• XuJWuCCheXCirculating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitisMol Carcinog201150213614221229610
   PubMed Web of Science ®Google Scholar
• CermelliSRuggieriAMarreroJAIoannouGNBerettaLCirculating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver diseasePLoS One201168e2393721886843
   PubMed Web of Science ®Google Scholar
• TomimaruYEguchiHNaganoHCirculating microRNA-21 as a novel biomarker for hepatocellular carcinomaJ Hepatol201256116717521749846
   PubMed Web of Science ®Google Scholar
• TrebickaJAnadolEElfimovaNHepatic and serum levels of miR-122 after chronic HCV-induced fibrosisJ Hepatol201358223423923085648
   PubMed Web of Science ®Google Scholar
• van der MeerAJFaridWRSonneveldMJSensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122J Viral Hepat201320315816623383654
   PubMed Web of Science ®Google Scholar
• KrutzfeldtJRajewskyNBraichRSilencing of microRNAs in vivo with ‘antagomirs’Nature2005438706868568916258535
   PubMed Web of Science ®Google Scholar
• ElmenJLindowMSchutzSLNA-mediated microRNA silencing in non-human primatesNature2008452718989689918368051
   PubMed Web of Science ®Google Scholar
• MercatelliNCoppolaVBonciDThe inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in micePLoS One2008312e402919107213
   PubMed Web of Science ®Google Scholar
• FelicettiFErricoMCBotteroLThe promyelocytic leukemia zinc fnger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanismsCancer Res20086882745275418417445
   PubMed Web of Science ®Google Scholar
• Di MartinoMTGullaACantafioMEIn vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myelomaOncotarget20134224225523479461
   PubMed Web of Science ®Google Scholar
• ParkJKKogureTNuovoGJmiR-221 silencing blocks hepatocellular carcinoma and promotes survivalCancer Res201171247608761622009537
   PubMed Web of Science ®Google Scholar
• LeoneEMorelliEDi MartinoMTTargeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growthClin Cancer Res20131982096210623446999
   PubMed Web of Science ®Google Scholar
• LindowMKauppinenSDiscovering the first microRNA-targeted drugJ Cell Biol2012199340741223109665
   PubMed Web of Science ®Google Scholar
• LanfordREHildebrandt-EriksenESPetriATherapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infectionScience2010327596219820119965718
   PubMed Web of Science ®Google Scholar
• Hildebrandt-EriksenESAarupVPerssonRHansenHFMunkMEOrumHA locked nucleic acid oligonucleotide targeting microRNA 122 is well-tolerated in cynomolgus monkeysNucleic Acid Ther201222315216122545703
   PubMed Web of Science ®Google Scholar
• KotaJChivukulaRRO’DonnellKATherapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer modelCell200913761005101719524505
   PubMed Web of Science ®Google Scholar
• HeXXChangYMengFYMicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivoOncogene201231283357336922056881
   PubMed Web of Science ®Google Scholar
• XiongYFangJHYunJPEffects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinomaHepatology201051383684520041405
   PubMed Web of Science ®Google Scholar
• AkaoYNakagawaYHirataIRole of anti-oncomirs miR-143 and -145 in human colorectal tumorsCancer Gene Ther201017639840820094072
   PubMed Web of Science ®Google Scholar
• KitadeYAkaoYMicroRNAs and their therapeutic potential for human diseases: microRNAs, miR-143 and -145, function as anti-oncomirs and the application of chemically modified miR-143 as an anti-cancer drugJ Pharmacol Sci2010114327628020953119
   PubMed Web of Science ®Google Scholar
• IbrahimAFWeirauchUThomasMGrunwellerAHartmannRKAignerAMicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinomaCancer Res201171155214522421690566
   PubMed Web of Science ®Google Scholar
• ValastyanSChangABenaichNReinhardtFWeinbergRAActivation of miR-31 function in already-established metastases elicits metastatic regressionGenes Dev201125664665921406558
   PubMed Web of Science ®Google Scholar
• BaderAGmiR-34 – a microRNA replacement therapy is headed to the clinicFront Genet2012312022783274
   PubMedGoogle Scholar
• KasinskiALSlackFJmiRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinomaCancer Res201272215576558722964582
   PubMed Web of Science ®Google Scholar
• Di MartinoMTLeoneEAmodioNSynthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidenceClin Cancer Res201218226260627023035210
   PubMed Web of Science ®Google Scholar
• LouWChenQMaLOncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor modelJ Mol Med (Berl)201391671572523292172
   PubMed Web of Science ®Google Scholar
• BischoffJRKirnDHWilliamsAAn adenovirus mutant that replicates selectively in p53-deficient human tumor cellsScience199627452863733768832876
   PubMed Web of Science ®Google Scholar
• MathisJMStoff-KhaliliMACurielDTOncolytic adenoviruses – selective retargeting to tumor cellsOncogene200524527775779116299537
   PubMed Web of Science ®Google Scholar
• AlemanyRCancer selective adenovirusesMol Aspects Med2007281425817300834
   PubMed Web of Science ®Google Scholar
• GanlyIKirnDEckhardtGA phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancerClin Cancer Res20006379880610741699
   PubMed Web of Science ®Google Scholar
• NemunaitisJGanlyIKhuriFSelective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trialCancer Res200060226359636611103798
   PubMed Web of Science ®Google Scholar
• GalanisEOkunoSHNascimentoAGPhase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomasGene Ther200512543744515647767
   PubMed Web of Science ®Google Scholar
• OpyrchalMAdercaIGalanisEPhase I clinical trial of locoregional administration of the oncolytic adenovirus ONYX-015 in combination with mitomycin-C, doxorubicin, and cisplatin chemotherapy in patients with advanced sarcomasMethods Mol Biol200954270571719565928
   PubMedGoogle Scholar
• KhuriFRNemunaitisJGanlyIA controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancerNat Med20006887988510932224
   PubMed Web of Science ®Google Scholar
• NemunaitisJSwisherSGTimmonsTAdenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancerJ Clin Oncol200018360962210653876
   PubMed Web of Science ®Google Scholar
• PatelMRKratzkeRAOncolytic virus therapy for cancer: the first wave of translational clinical trialsTransl Res2013161435536423313629
   PubMed Web of Science ®Google Scholar
• HuJCCoffinRSDavisCJA phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factorClin Cancer Res200612226737674717121894
   PubMed Web of Science ®Google Scholar
• HarringtonKJHingoraniMTanayMAPhase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neckClin Cancer Res201016154005401520670951
   PubMed Web of Science ®Google Scholar
• CerulloVPesonenSDiaconuIOncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patientsCancer Res201070114297430920484030
   PubMed Web of Science ®Google Scholar
• PesonenSDiaconuICerulloVIntegrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumorsInt J Cancer201213081937194721630267
   PubMed Web of Science ®Google Scholar
• KanervaANokisalmiPDiaconuIAnti-viral and anti-tumor T-cell immunity in patients treated with GMCSF coding oncolytic adenovirusClin Cancer Res201319102734274423493351
   PubMed Web of Science ®Google Scholar
• ParkBHHwangTLiuTCUse of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trialLancet Oncol20089653354218495536
   PubMed Web of Science ®Google Scholar
• HwangTHMoonABurkeJA mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanomaMol Ther201119101913 –21772252
   PubMed Web of Science ®Google Scholar
• HeoJReidTRuoLRandomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancerNat Med201319332933623396206
   PubMed Web of Science ®Google Scholar
• KellyEJHadacEMGreinerSRussellSJEngineering microRNA responsiveness to decrease virus pathogenicityNat Med200814111278128318953352
   PubMed Web of Science ®Google Scholar
• YlosmakiEHakkarainenTHemminkiAVisakorpiTAndinoRSakselaKGeneration of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNAJ Virol20088222110091101518799589
   PubMed Web of Science ®Google Scholar
• YlosmakiELavilla-AlonsoSJaamaaSMicroRNA-mediated suppression of oncolytic adenovirus replication in human liverPLoS One201381e5450623349911
   PubMed Web of Science ®Google Scholar
• CawoodRChenHHCarrollFBazan-PeregrinoMvan RooijenNSeymourLWUse of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cellsPLoS Pathog200955e100044019461878
   PubMed Web of Science ®Google Scholar
• CawoodRWongSLDiYBabanDFSeymourLWMicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activityPLoS One201161e1615221264344
   PubMed Web of Science ®Google Scholar
• LejaJNilssonBYuDDouble-detargeted oncolytic adenovirus shows replication arrest in liver cells and retains neuroendocrine cell killing abilityPLoS One201051e891620111709
   PubMed Web of Science ®Google Scholar
• JinHLvSYangJUse of microRNA Let-7 to control the replication specificity of oncolytic adenovirus in hepatocellular carcinoma cellsPLoS One201167e2130721814544
   PubMed Web of Science ®Google Scholar
• NguyenLVVannerRDirksPEavesCJCancer stem cells: an evolving conceptNat Rev Cancer201212213314322237392
   PubMed Web of Science ®Google Scholar
• SuhMRLeeYKimJYHuman embryonic stem cells express a unique set of microRNAsDev Biol2004270248849815183728
   PubMed Web of Science ®Google Scholar
• HatfieldSDShcherbataHRFischerKANakaharaKCarthewRWRuohola-BakerHStem cell division is regulated by the microRNA pathwayNature2005435704497497815944714
   PubMed Web of Science ®Google Scholar
• MaSBiology and clinical implications of CD133(+) liver cancer stem cellsExp Cell Res2013319212613222999864
   PubMed Web of Science ®Google Scholar
• OishiNWangXWNovel therapeutic strategies for targeting liver cancer stem cellsInt J Biol Sci20117551753521552419
   PubMed Web of Science ®Google Scholar
• LeeTKCheungVCNgIOLiver tumor-initiating cells as a therapeutic target for hepatocellular carcinomaCancer Lett 2012582013 [Epub ahead of print.]
   Google Scholar
• PangRWPoonRTCancer stem cell as a potential therapeutic target in hepatocellular carcinomaCurr Cancer Drug Targets20121291081109422873219
   PubMed Web of Science ®Google Scholar
• BudhuAJiaHLForguesMIdentification of metastasis-related microRNAs in hepatocellular carcinomaHepatology200847389790718176954
   PubMed Web of Science ®Google Scholar
• HanZBZhongLTengMJIdentification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantationMol Oncol20126444545722552153
   PubMed Web of Science ®Google Scholar
• JiJShiJBudhuAMicroRNA expression, survival, and response to interferon in liver cancerN Engl J Med2009361151437144719812400
   PubMed Web of Science ®Google Scholar
• ViswanathanSRPowersJTEinhornWLin28 promotes transformation and is associated with advanced human malignanciesNat Genet200941784384819483683
   PubMed Web of Science ®Google Scholar
• ZhangYGuoXXiongLMicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinomaFEBS Lett2012586244362437023178713
   PubMed Web of Science ®Google Scholar
• LiWXieLHeXDiagnostic and prognostic implications of microRNAs in human hepatocellular carcinomaInt J Cancer200812371616162218649363
   PubMed Web of Science ®Google Scholar
• GuHGuoXZouLZhuHZhangJUpregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinomaMol Cell Biochem20133751–2233023291979
   PubMed Web of Science ®Google Scholar
• FuXWangQChenJClinical significance of miR-221 and its inverse correlation with p27 Kip(1) in hepatocellular carcinomaMol Biol Rep20113853029303520146005
   PubMed Web of Science ®Google Scholar
• RongMChenGDangYIncreased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitroBMC Cancer2013132123320393
   PubMed Web of Science ®Google Scholar
• ChenLJiangMYuanWTangHmiR-17-5p as a novel prognostic marker for hepatocellular carcinomaJ Invest Surg201225315616122583011
   PubMed Web of Science ®Google Scholar
• HanZBChenHYFanJWWuJYTangHMPengZHUpregulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantationJ Cancer Res Clin Oncol2012138115316122071603
   PubMed Web of Science ®Google Scholar
• ChenHYHanZBFanJWmiR-203 expression predicts outcome after liver transplantation for hepatocellular carcinoma in cirrhotic liverMed Oncol20122931859186521786180
   PubMed Web of Science ®Google Scholar
• MurakamiYTamoriAItamiSThe expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosisBMC Cancer2013139923496901
   PubMed Web of Science ®Google Scholar
• XuJZhuXWuLMicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/beta-catenin pathwayLiver Int201232575276022276989
   PubMed Web of Science ®Google Scholar
• QiPChengSQWangHLiNChenYFGaoCFSerum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infectionPLoS One2011612e2848622174818
   PubMed Web of Science ®Google Scholar
• LiJWangYYuWChenJLuoJExpression of serum miR-221 in human hepatocellular carcinoma and its prognostic significanceBiochem Biophys Res Commun20114061707321295551
   PubMed Web of Science ®Google Scholar
• GuiJTianYWenXSerum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologiesClin Sci (Lond)2011120518319320815808
   PubMed Web of Science ®Google Scholar
• LiuAMYaoTJWangWCirculating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort studyBMJ Open201222e000825
   PubMed Web of Science ®Google Scholar
• ShrivastavaSPetroneJSteeleRLauerGMBisceglieAMRayRBUpregulation of circulating miR-20a is correlated with hepatitis C virus mediated liver disease progressionHepatology262013 [Epub ahead of print.]
   Web of Science ®Google Scholar
• JiJYamashitaTBudhuAIdentification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cellsHepatology200950247248019585654
   PubMed Web of Science ®Google Scholar
• JiJYamashitaTWangXWWnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinomaCell Biosci201111421711587
   PubMed Web of Science ®Google Scholar
• XuCLiuSFuHMicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cellsEur J Cancer201046152828283620655737
   PubMed Web of Science ®Google Scholar
• MaSTangKHChanYPmiR-130b promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1Cell Stem Cell20107669470721112564
   PubMed Web of Science ®Google Scholar
• JungCJIyengarSBlahnikKREpigenetic modulation of miR-122 facilitates human embryonic stem cell self-renewal and hepatocellular carcinoma proliferationPLoS One2011611e2774022140464
   PubMed Web of Science ®Google Scholar
• JiaYLiuHZhuangQTumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145Oncol Rep20122761865187222378186
   PubMed Web of Science ®Google Scholar
• ZhangJLuoNLuoYPengZZhangTLiSmicroRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-MybInt J Oncol201240374775622025269
   PubMed Web of Science ®Google Scholar
• OishiNKumarMRRoesslerSTranscriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinomaHepatology20125651792180322707408
   PubMed Web of Science ®Google Scholar
• WuKDingJChenCHepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer developmentHepatology20125662255226722898879
   PubMed Web of Science ®Google Scholar
• XiaHOoiLLHuiKMMiR-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancerHepatology372013 [Epub ahead of print.]
   Web of Science ®Google Scholar
• XiaHOoiLLHuiKMMiR-214 targets beta-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinomaPLoS One201279e4420622962603
   PubMed Web of Science ®Google Scholar